logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (i) Distribution of new outpatient clients by age group for each primary drug

Substance<1515-1920-2425-2930-3435-3940-4445+Mean ageAge known (base)Age not known
Opiates5.439.929.712.46.63.31.80.822.4211627352
Cocaine6.242.126.412.86.33.81.51.022.2227505767
Stimulants12.363.716.44.91.60.80.20.118.863151536
Hypnotics and sedatives6.624.516.111.811.77.35.916.229.21570386
Hallucinogens14.564.216.82.81.00.10.50.118.41020232
Volatile substances50.642.54.90.41.20.00.00.416.124724
Cannabis 33.254.98.32.10.80.40.20.117.1234778725
Other substances 14.050.115.57.85.10.64.82.221.4692363
Total15.047.120.58.64.32.41.20.920.57723324385

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, MT, NL, SK, FI, SE 

 Last data available from Spain refer to 2004 

 The number of treatment clients in each country is listed in [Table TDI-7]. 

 See also ''TDI-106-New outpatient age at first use and primary drug.xls'' on distribution by country and ''General notes for interpreting data'' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - Table TDI outpatient treatment centres 

Page last updated: Monday, 12 November 2007